More than 30,000 people in the United States and 60,000 Europeans
will learn that they have pancreatic cancer this year.
The Pancreatic Duct is intended to offer a solid introduction
to pancreatic cancer. It is intended to provide credible information
about pancreatic cancer to enable the patient and their loved
ones to learn about the disease. To help them to understand and
better accept what is happening to them. And to help them participate
effectively as an active part of their health care team.
Information about the founder of this site and his experiences
with pancreatic cancer are located in the Founder
section.
An Explorative Randomised
Phase II Study of Sequential Chemotherapy in Advanced Upper Gastrointestinal
Cancer.
Berglund A, Byström
P, Johansson B, Nygren P, Frödin JE, Pedersen D, Letocha
H, Glimelius B.
Med Oncol. Epub 2009 Feb 11. Akademiska sjukhuset, University
of Uppsala, Sweden.
[Link
to Abstract]
Arterial and Venous Resection
for Pancreatic Adenocarcinoma: Operative and Long-Term Outcomes.
Martin RC 2nd, Scoggins
CR, Egnatashvili V, Staley CA, McMasters KM, Kooby DA.
Arch Surg. 2009 Feb;144(2):154-9. James Graham Brown Cancer Center,
University of Louisville School of Medicine, Kentucky.
[Link
to Abstract]
Capecitabine and Celecoxib
as Second-Line Treatment of Advanced Pancreatic and Biliary Tract
Cancers.
Pino MS, Milella M, Gelibter
A, Sperduti I, De Marco S, Nuzzo C, Bria E, Carpanese L, Ruggeri
EM, Carlini P, Cognetti F.
Oncology. 2009;76(4):254-61. Epub 2009 Feb 26. Regina Elena National
Cancer Institute, Rome, Italy.
[Link
to Abstract]
Surgical Palliation of Unresectable
Pancreatic Head Cancer in Elderly PatientS.
Hwang SI, Kim HO, Son
BH, Yoo CH, Kim H, Shin JH.
World J Gastroenterol. 2009 Feb 28;15(8):978-82. Kangbuk Samsung
Hospital, Sungkyunkwan University School of Medicine, Jongno-Ku,
Seoul, South Korea.
[Link
to Abstract]
